中国男科学杂志
中國男科學雜誌
중국남과학잡지
CHINESE JOURNAL OF ANDROLOGY
2014年
1期
29-33
,共5页
乜照燕%吴海峰%甄秀丽%张娜%郭丽娜%赵素英%吕翠婷
乜照燕%吳海峰%甄秀麗%張娜%郭麗娜%趙素英%呂翠婷
먀조연%오해봉%견수려%장나%곽려나%조소영%려취정
精子/畸形%卵胞浆内单精子注射,男性不育%受精
精子/畸形%卵胞漿內單精子註射,男性不育%受精
정자/기형%란포장내단정자주사,남성불육%수정
spermatozoa/abnormalities%intracytoplasmic sperm injection,male infertility%fertilization
目的:评估短时受精联合早期补救性卵胞浆内单精子注射(ICSI)术在重度畸形精子症患者中的临床应用。方法235例重度畸形精子症患者(1%≤精子正常形态率<5%)行体外受精-胚胎移植(IVF-ET)周期随机分组,101例直接实施ICSI为A组,134例实施短时受精联合早期补救性ICSI为B组,短时受精后4~5h行极体观察,其中109例大于30%可见双极体列为B1组,25例早期判断未见双极体或小于30%未见双极体行早期补救性ICSI术列为B2组。比较不同组受精率、卵裂率、优质胚胎率、胚胎种植率及临床结局。结果3组的卵子成熟率分别为83.93%,87.03%和90.48%,正常受精率分别为78.76%,72.49%和75.61%,异常受精率分别为6.11%,14.88%和9.76%,卵裂率分别为83.93%,85.89%和84.96%,优质胚胎率分别为49.45%,50.49%和53.23%,胚胎植入率分别为28.10%,26.67%和32.00%,临床妊娠率分别为43.66%,43.04%和47.62%,流产率分别为6.45%,8.82%和10.00%。3组的卵子成熟率、正常受精率、卵裂率、优质胚胎率、胚胎种植率、临床妊娠率、流产率差异均无统计学意义(P>0.05),异常受精率在B1组有增高趋势,与其它组比较差异无统计学意义(P>0.05)。结论短时受精联合早期补救性ICSI在重度畸形精子症患者有应用价值,可以最大限度的减少ICSI比率,获得好的临床结局。
目的:評估短時受精聯閤早期補救性卵胞漿內單精子註射(ICSI)術在重度畸形精子癥患者中的臨床應用。方法235例重度畸形精子癥患者(1%≤精子正常形態率<5%)行體外受精-胚胎移植(IVF-ET)週期隨機分組,101例直接實施ICSI為A組,134例實施短時受精聯閤早期補救性ICSI為B組,短時受精後4~5h行極體觀察,其中109例大于30%可見雙極體列為B1組,25例早期判斷未見雙極體或小于30%未見雙極體行早期補救性ICSI術列為B2組。比較不同組受精率、卵裂率、優質胚胎率、胚胎種植率及臨床結跼。結果3組的卵子成熟率分彆為83.93%,87.03%和90.48%,正常受精率分彆為78.76%,72.49%和75.61%,異常受精率分彆為6.11%,14.88%和9.76%,卵裂率分彆為83.93%,85.89%和84.96%,優質胚胎率分彆為49.45%,50.49%和53.23%,胚胎植入率分彆為28.10%,26.67%和32.00%,臨床妊娠率分彆為43.66%,43.04%和47.62%,流產率分彆為6.45%,8.82%和10.00%。3組的卵子成熟率、正常受精率、卵裂率、優質胚胎率、胚胎種植率、臨床妊娠率、流產率差異均無統計學意義(P>0.05),異常受精率在B1組有增高趨勢,與其它組比較差異無統計學意義(P>0.05)。結論短時受精聯閤早期補救性ICSI在重度畸形精子癥患者有應用價值,可以最大限度的減少ICSI比率,穫得好的臨床結跼。
목적:평고단시수정연합조기보구성란포장내단정자주사(ICSI)술재중도기형정자증환자중적림상응용。방법235례중도기형정자증환자(1%≤정자정상형태솔<5%)행체외수정-배태이식(IVF-ET)주기수궤분조,101례직접실시ICSI위A조,134례실시단시수정연합조기보구성ICSI위B조,단시수정후4~5h행겁체관찰,기중109례대우30%가견쌍겁체렬위B1조,25례조기판단미견쌍겁체혹소우30%미견쌍겁체행조기보구성ICSI술렬위B2조。비교불동조수정솔、란렬솔、우질배태솔、배태충식솔급림상결국。결과3조적란자성숙솔분별위83.93%,87.03%화90.48%,정상수정솔분별위78.76%,72.49%화75.61%,이상수정솔분별위6.11%,14.88%화9.76%,란렬솔분별위83.93%,85.89%화84.96%,우질배태솔분별위49.45%,50.49%화53.23%,배태식입솔분별위28.10%,26.67%화32.00%,림상임신솔분별위43.66%,43.04%화47.62%,유산솔분별위6.45%,8.82%화10.00%。3조적란자성숙솔、정상수정솔、란렬솔、우질배태솔、배태충식솔、림상임신솔、유산솔차이균무통계학의의(P>0.05),이상수정솔재B1조유증고추세,여기타조비교차이무통계학의의(P>0.05)。결론단시수정연합조기보구성ICSI재중도기형정자증환자유응용개치,가이최대한도적감소ICSI비솔,획득호적림상결국。
Objective To evaluate clinical application of short-period fertilization combined with early rescue intracytoplasmic sperm injection (ICSI) technique in fertilization of severe abnormal sperm. Methods Total 235 patients with severe teratozoospermia (1%≤Normal sperm morphology rate<5%)for in vitro fertilization-embryo transfer (IVF-ET) cycles for egg were randomly divided into two groups. 101 cases of direct implementation of the ICSI as group A, 134 cases for short-period fertilization combined with early rescue ICSI as group B. Among group B, cumulus cells were removed after fertilization 4~5h, second polar body of oocytes was observed, in which 109 cases more than 30%visible bipolar body as B1 group, 25 cases of early judgment no less than 30%of bipolar body performed early remedial ICSI surgery as a group B2.The fertilization rate, cleavage rate, high-quality embryo rate, implantation rate and clinical outcome were comparatively analyzed among different groups. Results Egg maturation rates of three groups were 83.93%, 87.03%and 90.48%respectively, normal fertilization rates were 78.76%, 72.49%and 75.61%, abnormal fertilization rates were 6.11%, 14.88%and 9.76%, cleavage rates were 83.93%, 85.89%and 84.96%, high-quality embryos were 49.45%, 50.49%and 53.23%, implantation rates were 28.10%, 26.67%and 32.00%, clinical pregnancy rates were 43.66%, 43.04%and 47.62%, miscarriage rates were 6.45%, 8.82%and 10.00%. there were no significant difference in egg maturation rate, normal fertilization rate, cleavage rate , high-quality embryo rate, implantation rate, clinical pregnancy, miscarriage rates among three groups different (P>0.05). Abnormal fertilization rate in group B had an increasing trend, but the difference was not statistically significant (P>0.05). Conclusion Short-period fertilization combined with early rescue Intracytoplasmic sperm injection (ICSI) show great value for fertilization of patients with severe abnormal sperm. A good clinical outcome can be obtained if minimizing the ICSI.